Liraglutide-Induced Liver Injury: A Case Report and Review.

ABSTRACT:

Introduction

Glucagon-like peptide-1 receptor agonists such as liraglutide have revolutionized the management of type 2 diabetes and obesity.

Case presentation

We present a case of a 30-year-old woman who developed drug-induced liver injury (DILI) to liraglutide, confirmed on histology, with resolution on cessation of liraglutide over 6 months.

Conclusion

DILI secondary to liraglutide appears to be a rare but an important adverse effect.

SUBMITTER: Lai M 

PROVIDER: S-EPMC12503594 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature